A development agreement granting the Company land for commercial manufacturing operations in Olathe, Kansas, was approved today by the City Council of Olathe, Kansas, according to Artio Medical, a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets.
Located on an 18-acre tract of land, Artio intends to construct two commercial manufacturing facilities, with plans for the first structure being around 50,000 square feet in size. According to the terms of the agreement, the Company has the right to construct a second building on the lot and to buy adjacent land for the construction of a third structure, possibly increasing the overall project area to more than 150,000 square feet and creating more than 200 new employment. Copaken Brooks has been picked by the Company to serve as advisers and developers on the project.
In a statement, Mr. Tim McKee, Chief Executive Officer of the Olathe Chamber of Commerce since 2011, said, “We are thrilled to announce the approval of this development agreement.” In terms of where to locate its commercial manufacturing activities, Artio had a number of alternatives, and we are pleased with their decision to maintain these jobs in the United States and relocate them to Olathe.
As Wendy Sawyer, Artio Medical’s Senior Vice President of Operations and Quality, put it, “This is an exciting time for Artio as we prepare for the commercialization of our first products and grow our commercial production capabilities.” This was made possible by the availability of a skilled labor force, a neighborhood with an extraordinary and affordable quality of life, the availability of nearby acreage to support future development, and an attractive incentive package.